DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
162 hedge funds and large institutions have $647M invested in DermTech, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 38 closing their positions.
76% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 34
62% more call options, than puts
Call options by funds: $13.9M | Put options by funds: $8.55M
8% less funds holding
Funds holding: 176 → 162 (-14)
23% less capital invested
Capital invested by funds: $845M → $647M (-$198M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
+$19.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$16.6M |
| 3 |
RA
Royce & Associates
New York
|
+$9.21M |
| 4 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
+$5.3M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$3.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$45.3M |
| 2 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$10.4M |
| 3 |
1WCM
12 West Capital Management
New York
|
-$6.24M |
| 4 |
LCG
Lisanti Capital Growth
New York
|
-$5.66M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.27M |
DMTK Hedge Fund Activity: Q3 2021 in Review
162 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q3 2021, worth a combined $647M — down 23% from $845M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of DMTK and 24 opened new positions — a net loss of 14 holders — while 34 trimmed existing stakes and 60 added.
The largest buyer was Marshall Wace Asia, opening a new position worth an estimated $19.5M. The largest seller was ISZO Capital Management, exiting entirely with an estimated $45.3M sold.
- 162 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q3 2021, down from 176 in Q2 2021.
- Funds reported $647M of DermTech, Inc. Common Stock stock for Q3 2021, down 23% quarter-over-quarter.
- 24 funds opened new DermTech, Inc. Common Stock positions in Q3 2021 and 38 closed out, a net change of -14 holders.
- The largest DermTech, Inc. Common Stock buyer in Q3 2021 was Marshall Wace Asia, an estimated $19.5M added.
- The largest DermTech, Inc. Common Stock seller in Q3 2021 was ISZO Capital Management, an estimated $45.3M sold.
Based on aggregated 13F filings for Q3 2021.